This is a 3-center (PIs: Drs. Otto, Pollack, Tolin) collaborative R01. In this application, we propose to further validate and expand upon one of the apparent striking successes of translational research. Specifically, basic research on the neural circuitry underlying fear extinction led to the examination of d-cycloserine, a partial agonist at the NMDA receptor in the amygdala, as an agent capable of enhancing extinction learning (Davis et al., 2006a;Davis et al., 2006b). Following successful validation of this strategy in the animal laboratory, Ressler et al. (2004) showed that single doses of d-cycloserine (DCS) could enhance extinction in a human exposure paradigm for height phobic adults. This exciting initial finding was replicated by our research team for the treatment of social anxiety disorder in outpatients (Hofmann et al., 2006), and we also have completed a pilot study indicating similar benefits for the treatment of other anxiety disorders. As discussed by Anderson and Insel (2006), these findings have the potential to foster significant advances in the treatment of anxiety disorders. The present study represents the further application of DCS for augmenting the effects of exposure- based cognitive-behavior therapy (CBT), now applied to the treatment of panic disorder with or without agoraphobia. In this application we propose a double-blind randomized controlled trial, conducted at three treatment sites, to compare the relative benefit of augmenting exposure-based CBT with DCS as compared to placebo for patients with panic disorder. In addition, by studying variability at specific gene sites as a predictor of treatment response, particularly for the effects of DCS augmentation, we seek to identify which patients may be particularly responsive to this form of brief, combined treatment. This study capitalizes on the recent successes in translational research to investigate the benefits of the addition of d-cycloserine to a program of brief exposure-based CBT for the treatment of panic disorder with or without agoraphobia. This study addresses an important public health issue by assessing an intervention that may help lead to a more efficient and effective application of empirically-based psychosocial interventions for the treatment of panic disorder and other anxiety disorders. This novel strategy of combining exposure-based treatment and d-cycloserine remains a particularly promising strategy among disappointing alternatives for the treatment of individuals with anxiety disorders, and our research will also provide valuable information on potential genetic moderators of both CBT efficacy as well as d-cycloserine enhancement of this efficacy.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH081116-05
Application #
8265909
Study Section
Special Emphasis Panel (ZMH1-ERB-P (01))
Program Officer
Hillefors, MI
Project Start
2008-04-24
Project End
2014-03-31
Budget Start
2012-04-01
Budget End
2014-03-31
Support Year
5
Fiscal Year
2012
Total Cost
$217,181
Indirect Cost
$83,531
Name
Boston University
Department
Psychology
Type
Schools of Arts and Sciences
DUNS #
049435266
City
Boston
State
MA
Country
United States
Zip Code
02215
Asnaani, Anu; Aderka, Idan M; Marques, Luana et al. (2015) The structure of feared social situations among race-ethnic minorities and Whites with social anxiety disorder in the United States. Transcult Psychiatry 52:791-807
Soravia, Leila M; Heinrichs, Markus; Winzeler, Livia et al. (2014) Glucocorticoids enhance in vivo exposure-based therapy of spider phobia. Depress Anxiety 31:429-35
Smoller, Jordan W; Gallagher, Patience J; Duncan, Laramie E et al. (2014) The human ortholog of acid-sensing ion channel gene ASIC1a is associated with panic disorder and amygdala structure and function. Biol Psychiatry 76:902-10
Emmelkamp, Paul M G; David, Daniel; Beckers, Tom et al. (2014) Advancing psychotherapy and evidence-based psychological interventions. Int J Methods Psychiatr Res 23 Suppl 1:58-91
Hofmann, Stefan G (2013) Can fMRI be used to predict the course of treatment for social anxiety disorder? Expert Rev Neurother 13:123-5
Khoury, Bassam; Lecomte, Tania; Fortin, Guillaume et al. (2013) Mindfulness-based therapy: a comprehensive meta-analysis. Clin Psychol Rev 33:763-71
Beard, Courtney; Sawyer, Alice T; Hofmann, Stefan G (2012) Efficacy of attention bias modification using threat and appetitive stimuli: a meta-analytic review. Behav Ther 43:724-40
Asnaani, Anu; Hofmann, Stefan G (2012) Collaboration in multicultural therapy: establishing a strong therapeutic alliance across cultural lines. J Clin Psychol 68:187-97
Otto, Michael W; Tolin, David F; Nations, Kari R et al. (2012) Five sessions and counting: considering ultra-brief treatment for panic disorder. Depress Anxiety 29:465-70
Hofmann, Stefan G; Ellard, Kristen K; Siegle, Greg J (2012) Neurobiological correlates of cognitions in fear and anxiety: a cognitive-neurobiological information-processing model. Cogn Emot 26:282-99

Showing the most recent 10 out of 15 publications